ZA944281B - Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease - Google Patents

Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease

Info

Publication number
ZA944281B
ZA944281B ZA944281A ZA944281A ZA944281B ZA 944281 B ZA944281 B ZA 944281B ZA 944281 A ZA944281 A ZA 944281A ZA 944281 A ZA944281 A ZA 944281A ZA 944281 B ZA944281 B ZA 944281B
Authority
ZA
South Africa
Prior art keywords
efaroxan
parkinson
disease
derivatives
preparation
Prior art date
Application number
ZA944281A
Other languages
English (en)
Inventor
Francis Colpaert
Michael Briley
Thierry Imbert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA944281B publication Critical patent/ZA944281B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA944281A 1993-06-18 1994-06-16 Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease ZA944281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307379A FR2706303B1 (fr) 1993-06-18 1993-06-18 Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Publications (1)

Publication Number Publication Date
ZA944281B true ZA944281B (en) 1995-02-10

Family

ID=9448287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944281A ZA944281B (en) 1993-06-18 1994-06-16 Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease

Country Status (15)

Country Link
US (1) US5948806A (xx)
EP (1) EP0703781B1 (xx)
JP (1) JP3394257B2 (xx)
AT (1) ATE192650T1 (xx)
AU (1) AU689783B2 (xx)
CA (1) CA2165437A1 (xx)
DE (1) DE69424415T2 (xx)
DK (1) DK0703781T3 (xx)
ES (1) ES2147576T3 (xx)
FR (1) FR2706303B1 (xx)
GR (1) GR3034062T3 (xx)
NZ (1) NZ268039A (xx)
PT (1) PT703781E (xx)
WO (1) WO1995000145A1 (xx)
ZA (1) ZA944281B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
JP2004513917A (ja) * 2000-11-14 2004-05-13 オリオン　コーポレーション ジスキネジーの発症の予防
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
FR2706303A1 (fr) 1994-12-23
FR2706303B1 (fr) 1995-09-08
GR3034062T3 (en) 2000-11-30
ATE192650T1 (de) 2000-05-15
DE69424415D1 (de) 2000-06-15
DK0703781T3 (da) 2000-10-02
ES2147576T3 (es) 2000-09-16
AU7076494A (en) 1995-01-17
WO1995000145A1 (fr) 1995-01-05
EP0703781A1 (fr) 1996-04-03
AU689783B2 (en) 1998-04-09
PT703781E (pt) 2000-10-31
CA2165437A1 (fr) 1994-12-19
JPH09500375A (ja) 1997-01-14
EP0703781B1 (fr) 2000-05-10
DE69424415T2 (de) 2000-12-21
US5948806A (en) 1999-09-07
JP3394257B2 (ja) 2003-04-07
NZ268039A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
EP0331620A3 (en) Agent for the treatment of parkinson's disease
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
HUP9900924A3 (en) Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
BG102667A (en) Diosgenine-containing composition
EP0744176A3 (en) Methods for inhibiting bone loss
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
CA2167257A1 (en) Use of Sertraline to Treat Cancer Patients
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
HU9502320D0 (en) Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU3429289A (en) Dithranol-containing pharmaceutical product for flaking skin diseases
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease